Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01916603
Other study ID # Fondecyt #1130277
Secondary ID
Status Not yet recruiting
Phase N/A
First received July 4, 2013
Last updated August 1, 2013
Start date September 2013
Est. completion date March 2017

Study information

Verified date July 2013
Source University of Chile
Contact Maria L Garmendia, PhD
Phone 56229781402
Email mgarmendia@inta.uchile.cl
Is FDA regulated No
Health authority Chile: Instituto de Salud Pública de ChileChile: Ministry of Health
Study type Interventional

Clinical Trial Summary

NCDs are observed mostly in adults, however there is strong evidence that suggests NCDs origin early in life, thus the first 1000 days of life (conception to age 2yrs). Studies show that maternal BMI before conception and during pregnancy predict future risk of obesity and associated metabolic conditions in both mother and offspring. Weight gain during the first two years of life is also critical in defining the infant's predisposition to obesity during adulthood. Objective: to assess the effectiveness of delivering a primary health care intervention to enhance compliance with updated nutrition and health care (diet, physical activity and breastfeeding) standards from early pregnancy through the first year of life. Methods: cluster randomized controlled trial (CRCT), designed as a public health intervention "program effectiveness" study (i.e. intervention will be available through the established national health system under standard operating conditions). A cluster unit will be a primary health care centers (PHCC) in South-East Santiago 12 PHCC will be randomly allocated to: enhanced nutrition and health care (intervention group) or routine nutrition and health care (control group).We will recruit 200 women in each of 12 PHCC; assuming a 20% loss to f-up we will complete 960 women per arm. After randomization, pregnant women in the intervention PHCCs starting at their first pre-natal visit (< 15 wks.) will receive, diet and physical activity (PA) counseling-support based on updated recommendations and monitoring goals for weight gain & glycemic control and breastfeeding (BF) promotion till 12 m postpartum. Pregnant women who attend control PHCCs will receive routine antenatal care according to national guidelines. Expected results: participants in the intervention PHCCs will benefit by achieving adequate nutritional status & metabolic control, during and early after, pregnancy as well as adequate infant growth & development as a result of improved nutrition and health care practices. The results will likely be generalizable through the primary health care system; considering this is a "program effectiveness" trial conducted under "real life" conditions . Additionally, we will include specific ancillary mechanistic projects to better characterize the intervention and its impact.


Description:

Introduction: in Chile as well as in most of the world, obesity and related chronic diseases (cardiovascular diseases, cancer and diabetes (NCDs)) are presently the main causes of death and disability. Although these conditions are observed mostly in adulthood, there is now considerable evidence that indicates that they are rooted in the first 1000 days of life (from -1 to + 2yrs of life).

Several studies show that maternal BMI before conception and during pregnancy predict future risk of obesity and associated metabolic conditions for both mother and offspring. Weight gain during the first two years of life is also critical, not only to ensure infant survival, but also in defining the infant's predisposition to the emergence of chronic diseases during adulthood. From a population perspective, the most effective approach to counteract the epidemic of obesity and NCDs is to prevent them. Recommendations for healthy diets and physical activity during pregnancy and infancy, as well as monitoring of nutrition goals are currently available in the Chilean primary health care system. However, most of these recommendations are not up to date and virtually all are poorly implemented. Objective: to assess the effectiveness of delivering (via primary health centers) an intervention that enhances compliance with up to date nutrition and health care standards (regarding diet, physical activity and breastfeeding promotion) during pregnancy and the first year of life. The main goal is that mothers achieve adequate nutritional status & metabolic control, during and early after pregnancy, and that infants grow and develop healthily (adequate linear and ponderal growth according to WHO standard, while avoiding excess BMI gains) Methods: this is a cluster randomized controlled trial (CRCT), designed as a public health "program effectiveness" study (i.e. intervention will be available through the established national health system under standard operating conditions). The cluster units will be 12 primary health care centers (PHCC) in South-East Santiago randomly allocated to: 1) enhanced nutrition and health care standards (intervention group) or 2) routine care (control group).

Women seeking care before 15 weeks of pregnancy, residents within a catchment area of selected PHCCs, who are not planning to move in the next two years will be invited to participate in the study. Pregnant women classified as high risk according to the norms of the Chilean Ministry of Health (MoH)and/or underweight (BMI<18.5) will be excluded. We will recruit 200 women in each PHCC and assuming a 20% loss to f-up we will end with 960 women per arm of the study. After randomization, pregnant women in the intervention PHCCs starting at their first pre-natal visit (< 15 wks.) will receive, diet and physical activity (PA) counseling-support based on updated recommendations and monitoring goals for weight gain & glycemic control and breastfeeding (BF) promotion till 12 months postpartum. Pregnant women who attend control PHCCs will receive routine antenatal care according to national guidelines. The outcomes will be: 1)achievement of adequate nutritional status & metabolic control during pregnancy: a. Weight gain according to Institute of Medicine (IOM) recommendations, b. glycemic control based on ADA 2011 recommendations, 3. No weight retention at 12 months, and 2) healthy infant growth and development: a) height and BMI growth based on WHO standards, b) normal abbreviated psychomotor development test (TEPSI) and evaluation scale of psychomotor development (EEDP) at 12 months. Mothers & infants will be monitored to ensure the safety of the intervention (assessment of undernutrition, micronutrient deficiency and indices of poor nutrition). Data will be collected as part of routine health care activities and analyzed based on the allocation to each study group ("intention to treat"). Results will be presented as appropriate effect sizes with a measure of precision (95% confidence intervals). Further exploratory analyses will be based on those participants that fully follow the protocol ("per-protocol analyses"). Expected results: we expect that the intervention will benefit the participants in achieving adequate nutritional status & metabolic control, during and early after, pregnancy as well as adequate infant growth & development as a result of an increase in the impact of standard nutrition and health care practices. The results should be potentially extended to the rest of the primary health care system given the "program effectiveness" approach that will be taken. Additionally, we expect that this study will serve as a core project in which other ancillary projects will be nested. Gathered information should contribute to a better understanding of how to develop effective interventions to halt the maternal and obesity epidemic and its associated co-morbidities in the Chilean population.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 2400
Est. completion date March 2017
Est. primary completion date September 2013
Accepts healthy volunteers No
Gender Female
Age group 16 Years to 40 Years
Eligibility Inclusion Criteria:

- Women seeking care before 15 weeks of pregnancy, residents within catchment area of selected Primary Health Care Centers, who are not planning to move in the next two years will be invited to participate in the study

Exclusion Criteria:

- Pregnant women classified as high risk according to the norms of the Chilean Ministry of Health(MoH) and/or underweight (BMI<18.5)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Prevention


Intervention

Behavioral:
Normative Intervention
Diet and physical activity counselling-support and breastfeeding promotion till 12 months postpartum

Locations

Country Name City State
Chile Institute of Nutrition and Food Technology Santiago Región Metropolitana

Sponsors (5)

Lead Sponsor Collaborator
University of Chile Fondo Nacional de Desarrollo Científico y Tecnológico, Chile, Ministry of Health, Chile, National Nutrition and Food Technology Institute, Pontificia Universidad Catolica de Chile

Country where clinical trial is conducted

Chile, 

Outcome

Type Measure Description Time frame Safety issue
Primary Weight gain and nutritional status in mothers 36-40 weeks of gestation Yes
Primary Weight retention 12 months post-partum Yes
Primary Glycaemic control At 20-24 weeks of pregnancy Yes
Primary Lactation rates At 12 months post-partum Yes
Primary Initiation and duration of breastfeeding (exclusive and total) Birth-12 months Yes
Primary Weight, length and BMI growth in infants During the first year of life Yes
Primary Psychomotor development (based on abbreviated scale) During the first year of life Yes
Secondary Implementation Implementation: compliance to protocol by health personnel, midwives & dieticians per center, time allocated to the actions of the interventions, etc. At 30 months into the recruitment Yes
Secondary Participant compliance variables Variables relate to the adoption by participants of the respective program activities: adherence to diet/physical activity prescriptions, adequate referral, attendance to dietician's clinic, lactation workshops, etc. At 30 months into the recruitment Yes
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2